REQUEST A DEMO
Total
USD $0.00
Search more companies

Siriporn Pharmacy Company Limited (Thailand)

Main Activities: Pharmacies and Drug Stores
Full name: Siriporn Pharmacy Company Limited Profile Updated: March 31, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Siriporn Pharmacy Company Limited is an enterprise based in Thailand. Its main office is in Ubon Ratchathani. It operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on May 20, 2026. It currently has a total number of 7 (estimated) employees. The company’s latest financial report indicates a net sales revenue increase of 39.5% in 2024. Its’ total assets recorded a growth of 6.96%. The net profit margin of Siriporn Pharmacy Company Limited decreased by 0.87% in 2024.

Headquarters
19 Moo 8 Wisitsri Road Soi Wisitsri 5
Ubon Ratchathani; North-Eastern Thailand; Postal Code: 34170

Contact Details: Purchase the Siriporn Pharmacy Company Limited report to view the information.

Basic Information
Total Employees:
Purchase the Siriporn Pharmacy Company Limited report to view the information.
Financial Auditors:
Purchase the Siriporn Pharmacy Company Limited report to view the information.
Incorporation Date:
May 20, 2026
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Siriporn Pharmacy Company Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency THB. Absolute financial data is included in the purchased report.
Net sales revenue
39.5%
Total Operating Revenue
41.43%
Operating Profit
-42.53%
EBITDA
-42.53%
Net Profit/Loss for the Period
-45.07%
Total Assets
6.96%
Total Equity
17.4%
Operating Profit Margin
-1.27%
Net Profit Margin
-0.87%
Return on Equity (ROE)
-16.85%
Debt / Equity
-109.69%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?